Clinical Trial Update: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the impact of semaglutide on cardiovascular outcomes in adults with Type 1 diabetes is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Semaglutide (Ozempic) (semaglutide)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Diabetes Mellitus, Type 1 | Phase 3 | Status: RECRUITING